Suppr超能文献

在转诊至伊拉姆诊所的患者中,比较质子泵抑制剂(PPI)+阿莫西林+利福平与质子泵抑制剂(PPI)+阿莫西林+左氧氟沙星这两种药物治疗方案对一线治疗方案耐药感染的治疗效果。

Comparison between the two drug regimens of PPI+Amoxicillin+ Rifampicin and PPI+Amoxicillin+ Levofloxacin for the treatment of infections resistant to the first line drug regimen among patients referred to Ilam clinics.

作者信息

Abangah Ghobad, Raughani Alireza, Asadollahi Parisa, Asadollahi Khairollah

机构信息

Department of Internal Medicine, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.

Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.

出版信息

Gastroenterol Hepatol Bed Bench. 2019 Summer;12(3):209-216.

Abstract

AIM

This study compares the effects of two drug regimens for () infection resistant to the first line drug regimen among patients referred to Ilam clinics, Iran.

BACKGROUND

Single drug regimen is not effective for infection and therefore, application of triple or quadruple drug regimens are currently applied.

METHODS

This study was performed by a before-after comparative method and patients were randomly selected among those consecutively referred to Ilam gastrointestinal clinics. Patients with failure in the first line treatment, were randomly divided into two equal groups and each group was treated by one of the PPI+Amoxicillin+Rifampicin or PPI+Amoxicillin+Levofloxacin drug regimens for 14 days. Six weeks after treatment, patients were tested for stool antigen and the results were compared between two groups.

RESULTS

In this study, 100 patients including 49 (49%) men and 51 (51%) women were examined. There was no statistical difference between the two groups for gender, age and living location at the start of study (p = 0.068). The mean age of the patients was 44.55 ±15.1 years old ranging from 17 to 85 years. Response to treatment among the levofloxacin group, was 90% and in rifampicin group 72% with a significant difference (p<0.04).

CONCLUSION

The response rate of infection to the Levofloxacin based regimen was 90%; however, the application of rifampicin in combination with other drugs against infection (72% response rate), should be limited to reduce the possibility of drug resistance in case of tuberculosis infection.

摘要

目的

本研究比较了两种药物治疗方案对转诊至伊朗伊拉姆诊所的患者中对一线药物治疗方案耐药的()感染的疗效。

背景

单一药物治疗方案对()感染无效,因此目前应用三联或四联药物治疗方案。

方法

本研究采用前后对比法进行,患者从连续转诊至伊拉姆胃肠诊所的患者中随机选取。一线治疗失败的患者被随机分为两组,每组分别接受PPI + 阿莫西林 + 利福平或PPI + 阿莫西林 + 左氧氟沙星药物治疗方案之一,治疗14天。治疗六周后,对患者进行()粪便抗原检测,并比较两组结果。

结果

本研究共检查了100例患者,其中男性49例(49%),女性51例(51%)。研究开始时,两组在性别、年龄和居住地点方面无统计学差异(p = 0.068)。患者的平均年龄为44.55±15.1岁,年龄范围为17至85岁。左氧氟沙星组的治疗有效率为90%,利福平组为72%,差异有统计学意义(p<0.04)。

结论

基于左氧氟沙星的治疗方案对()感染的有效率为90%;然而,利福平与其他抗()感染药物联合应用(有效率72%)应加以限制,以降低结核病感染时产生耐药性的可能性。

相似文献

2
Optimum duration of regimens for Helicobacter pylori eradication.
Cochrane Database Syst Rev. 2013 Dec 11;2013(12):CD008337. doi: 10.1002/14651858.CD008337.pub2.
4
Second-line rescue treatment of infection: Where are we now?
World J Gastroenterol. 2018 Oct 28;24(40):4548-4553. doi: 10.3748/wjg.v24.i40.4548.
5
'Rescue' therapies for the management of Helicobacter pylori infection.
Dig Dis. 2006;24(1-2):113-30. doi: 10.1159/000090315.
9
Helicobacter pylori and gastric or duodenal ulcer.
Prescrire Int. 2016 Jan;25(167):18-23.

引用本文的文献

1
An Update on Eradication of in Iran: A Review.
Middle East J Dig Dis. 2024 Jul;16(3):147-154. doi: 10.34172/mejdd.2024.389. Epub 2024 Jul 31.
2
The Efficacy, Safety, and Tolerability of Levofloxacin Quadruple Therapy for Eradication: A Randomized, Double-Blind Clinical Trial.
Evid Based Complement Alternat Med. 2022 Dec 6;2022:9794901. doi: 10.1155/2022/9794901. eCollection 2022.

本文引用的文献

2
Helicobacter pylori infection: old and new.
J Med Life. 2017 Apr-Jun;10(2):112-117.
3
Management of Helicobacter pylori infections.
BMC Gastroenterol. 2016 Aug 12;16(1):94. doi: 10.1186/s12876-016-0496-2.
4
Treatment of Helicobacter pylori infection: Current and future insights.
World J Clin Cases. 2016 Jan 16;4(1):5-19. doi: 10.12998/wjcc.v4.i1.5.
5
Diagnostic methods for H. pylori infection: Choices, opportunities and pitfalls.
United European Gastroenterol J. 2015 Oct;3(5):429-31. doi: 10.1177/2050640615600968.
8
Treatment of Helicobacter pylori infection: current status and future concepts.
World J Gastroenterol. 2014 May 14;20(18):5283-93. doi: 10.3748/wjg.v20.i18.5283.
9
Review article: Associations between Helicobacter pylori and obesity--an ecological study.
Aliment Pharmacol Ther. 2014 Jul;40(1):24-31. doi: 10.1111/apt.12790. Epub 2014 May 15.
10
Gastric cancer: Classification, histology and application of molecular pathology.
J Gastrointest Oncol. 2012 Sep;3(3):251-61. doi: 10.3978/j.issn.2078-6891.2012.021.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验